FindTrial
Sign In

A phase II study of NK105 for patients with previously treated advanced or recurrent gastric cancer.

A phase II study of NK105 for patients with previously treated advanced or recurrent gastric cancer.

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220741
Enrollment
Unknown
Registered
2009-06-05
Start date
2009-06-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

investigational material(s) Generic name etc : NK105 (antineoplastic preparations extracted from plants) INN of investigational material : Therapeutic category code : 424 Antineoplastic preparations

Sponsors

Nippon Kayaku Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Gastric cancer confirmed by histological diagnosis or cytologic diagnosis 2. Failure to one prior chemotherapy regimen for gastric cancer 3. Adequate organ function, etc

Exclusion criteria

Exclusion criteria: Priory treatments should not have included taxanes. etc

Design outcomes

Primary

MeasureTime frame
Response propotion—

Secondary

MeasureTime frame
Adverse events Time to treatment failure Progression-free survival Overall survival—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026